UK buying guide
Buy Retatrutide (Reta) for UK laboratory research
Retatrutide — often abbreviated Reta in laboratory literature — is the most studied triple-agonist in metabolic research, acting on GIP, GLP-1 and glucagon receptor pathways. SupplyPeptides has supplied UK research institutions with GLP-1 pathway compounds for over a decade.
Research context
In preclinical and in-vitro models, Retatrutide is investigated as a synthetic peptide targeting three incretin-related pathways simultaneously. UK laboratories sourcing Retatrutide typically need verifiable purity data, a batch-specific Certificate of Analysis, and a supplier that does not blur research supply with human-use marketing.
How SupplyPeptides verifies every batch
Every Retatrutide lot in our UK warehouse passes three checks before listing: HPLC purity assay (≥99%), mass-spec identity confirmation, and physical QC of lyophilisation quality and vial integrity. The COA for your batch is published in our COA library — searchable by lot number before you order. Batches that do not meet threshold are not listed for sale.
Look up batch paperwork in our COA library, or read our guide on HPLC-tested peptides in the UK.
How this compound compares in research
| Attribute | Retatrutide | Tirzepatide | Semaglutide |
|---|---|---|---|
| Receptor targets | GIP + GLP-1 + Glucagon | GIP + GLP-1 | GLP-1 only |
| Agonist class | Triple agonist | Dual agonist | GLP-1 agonist |
| Common research abbreviation | Reta | Tirz | Sema |
All materials are Research Use Only. Comparison is for laboratory procurement orientation, not therapeutic guidance.
Retatrutide — UK in stock
Retatrutide
From
View product & batch COA →
Explore
Related pages
FAQ
Buy Retatrutide UK — FAQ
What is Retatrutide used for in research?
Retatrutide is a synthetic triple-agonist peptide studied in laboratory research targeting GIP, GLP-1 and glucagon receptor pathways. It is supplied strictly for in-vitro and laboratory research use, not for human or veterinary use.
Where can I buy Retatrutide in the UK?
SupplyPeptides stocks Retatrutide in UK warehouse with same-day Royal Mail 24 dispatch. Every batch is HPLC-tested with a published Certificate of Analysis searchable in our COA library.
How does Retatrutide compare to Tirzepatide and Semaglutide?
Retatrutide targets three receptor pathways (GIP, GLP-1 and glucagon), whereas Tirzepatide is a dual GIP/GLP-1 agonist and Semaglutide is a GLP-1 agonist. All three are supplied as Research Use Only materials for laboratory study.
Is Retatrutide approved for human use?
No. Retatrutide is Research Use Only (RUO) and is not intended for human or veterinary consumption, dosing, or therapeutic use.